# A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler

> **NCT02148120** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 60 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Beclometasone Dipropionate 100 µg + Formoterol Fumarate 6 µg
- **DRUG:** Beclometasone Dipropionate 200 µg + Formoterol Fumarate 6 µg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02148120
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02148120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02148120, "A Study to Evaluate the Acute Bronchodilator Effect of CHF1535 NEXThaler". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02148120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*